Psychogenic nonepileptic seizures, conversion, and somatic symptom disorders
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published January 4, 2019.
Article Versions
- Previous version (January 4, 2019 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Selim R. Benbadis, MD
- Selim R. Benbadis, MD
Advisory Board for Cyberonics/LivaNova, Eisai, Greenwich, Lundbeck, Neuropace, Sunovion.
NONE
NONE
Editorial Board: Emedicine-Medscape-WebMD, European Neurology, Epileptic Disorders, Epilepsy and Behavior, Expert Review of Neurotherapeutics.
NONE
1. UpToDate. 2. Medscape/WebMD.
NONE
Cyberonics/LivaNova, Eisai, Greenwich, Lundbeck, Neuropace, Sunovion.
Speakers Bureau: Cyberonics/LivaNova, Eisai, Greenwich, Lundbeck, Neuropace, Sunovion.
NONE
The University of South Florida (Tampa General Hospital) Epilepsy Center is a level-4 center, and as such performs all available treatment: medications, neurostimulation, and surgery.
Clinical trials: Cavion, LivaNova, GW, Sunovion, UCB.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Correspondence
Dr. Benbadis sbenbadi{at}health.usf.edu
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
- Response to Dr. Sethi
- Selim R. Benbadis, Neurologist, University of South Florida
Submitted January 25, 2019 - Psychogenic non-epileptic seizures: Make the diagnosis unequivocally
- Nitin K. Sethi, Associate Professor of Neurology, New York-Presbyterian Hospital, Weill Cornell Medical Center (New York, NY)
Submitted January 13, 2019
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.